X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (30) 30
humans (29) 29
female (22) 22
male (22) 22
middle aged (21) 21
glioma (19) 19
oncology (19) 19
adult (16) 16
aged (15) 15
clinical neurology (14) 14
tumors (14) 14
nuclear medicine (13) 13
magnetic resonance imaging (12) 12
medicine & public health (12) 12
retrospective studies (12) 12
tomography (12) 12
tyrosine - analogs & derivatives (12) 12
brain neoplasms - diagnostic imaging (11) 11
positron-emission tomography (10) 10
prognosis (10) 10
young adult (10) 10
positron emission (9) 9
brain (8) 8
glioma - diagnostic imaging (8) 8
neurology (8) 8
positron-emission-tomography (8) 8
radiology, nuclear medicine & medical imaging (8) 8
treatment outcome (8) 8
abstracts (7) 7
adolescent (7) 7
aged, 80 and over (7) 7
kinetic analysis (7) 7
patients (7) 7
positron emission tomography (7) 7
radiopharmaceuticals (7) 7
brain neoplasms - mortality (6) 6
brain neoplasms - pathology (6) 6
brain tumors (6) 6
fet-pet (6) 6
gliomas (6) 6
kinetics (6) 6
medical prognosis (6) 6
positron-emission tomography - methods (6) 6
prognostic value (6) 6
brachytherapy - methods (5) 5
brain cancer (5) 5
c-11-methionine pet (5) 5
cardiology (5) 5
chemotherapy (5) 5
classification (5) 5
fluorine isotopes (5) 5
follow-up studies (5) 5
glioblastoma (5) 5
glioblastoma - pathology (5) 5
glioma - pathology (5) 5
imaging / radiology (5) 5
mutation (5) 5
neoplasm grading (5) 5
orthopedics (5) 5
surgery (5) 5
survival (5) 5
tyrosine (5) 5
amino acids (4) 4
brain neoplasms - radiotherapy (4) 4
brain neoplasms - therapy (4) 4
brain-tumors (4) 4
care and treatment (4) 4
cerebral gliomas (4) 4
child (4) 4
contrast media (4) 4
disease-free survival (4) 4
dna methylation (4) 4
dynamic f-18-fet pet (4) 4
f-fet pet (4) 4
fet pet (4) 4
glioblastoma - mortality (4) 4
glioblastoma multiforme (4) 4
low-grade glioma (4) 4
malignant glioma (4) 4
medical imaging (4) 4
methylation (4) 4
neuroimaging (4) 4
o--l-tyrosine pet (4) 4
original research (4) 4
parameters (4) 4
pet (4) 4
prospective studies (4) 4
radiosurgery (4) 4
radiotherapy (4) 4
response assessment (4) 4
subgroups (4) 4
temozolomide (4) 4
analysis (3) 3
antineoplastic agents, alkylating - therapeutic use (3) 3
biological transport (3) 3
brain - diagnostic imaging (3) 3
brain neoplasms - drug therapy (3) 3
brain neoplasms - metabolism (3) 3
brain neoplasms - surgery (3) 3
brain tumor (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Discovery Medicine, ISSN 1539-6509, 2015, Volume 20, Issue 112, pp. 403 - 411
Deep Brain Stimulation (DBS) has proven to be an effective and minimally invasive surgical treatment for a variety of neurological and psychiatric diseases... 
Deep Brain Stimulation - trends | Mental Disorders - therapy | Humans | Deep Brain Stimulation - methods | Nervous System Diseases - therapy
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 6/2012, Volume 39, Issue 6, pp. 1021 - 1029
Journal Article
The Lancet, ISSN 0140-6736, 02/2019, Volume 393, Issue 10172, pp. 678 - 688
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 11/2019, Volume 46, Issue 12, pp. 2581 - 2589
Purpose According to the updated WHO classification of gliomas with its emphasis on molecular parameters, tumours with an IDH-wildtype status have a dismal... 
Prognosis | Parameters | Positron emission | Fluorine isotopes | Subgroups | Magnetic resonance imaging | Glioma | Predictions | Diagnostic software | Tomography | Diagnostic systems | Mutation | Genotypes | Tumors
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 05/2019, Volume 60
Background: Within the updated 2016 WHO classification, gliomas are stratified into separate molecular genetic entities. Among these subgroups, IDH-mutant,... 
Decision making | Brain cancer | Glioblastoma | Positron emission | Fluorine isotopes | Oncology | Multivariate analysis | Patients | Morbidity | Subgroups | Oligodendroglioma | Magnetic resonance imaging | Medical prognosis | Biomarkers | Tomography | Positron emission tomography | Tumors
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 9/2018, Volume 139, Issue 3, pp. 721 - 730
Monitoring treatment response after chemotherapy of gadolinium-(Gd)-negative gliomas is challenging as conventional MRI often indicates no radiological... 
FET-PET | Neurology | Chemotherapy | Medicine & Public Health | Glioma | Oncology | Metabolic response | Neuroimaging | Magnetic resonance imaging | Brain tumors | Alkylating agents | Biomarkers | Gadolinium | Temozolomide | Patients | Positron emission tomography | Movement disorders
Journal Article
Neuro-Oncology, ISSN 1522-8517, 11/2018, Volume 20, Issue suppl_6, pp. vi156 - vi157
Abstract INTRODUCTION The revision of the WHO classification in 2016 introduced brain invasion as a per se sufficient condition for meningiomas to be... 
Abstracts
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 12/2019, Volume 145, Issue 3, pp. 469 - 477
For meningiomas, the 2016 revision of the WHO classification introduced brain invasion per se as a sufficient condition to classify as grade II. We analyzed... 
Neurology | Medicine & Public Health | Microscopic brain invasion | Prognostic factor | Oncology | WHO grade I | Meningioma
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 12/2014, Volume 120, Issue 3, pp. 615 - 623
Treatment options for inoperable glioblastoma are limited. Low-dose-rate stereotactic iodine-125 brachytherapy (SBT) has been reported as an effective and... 
Neurology | Interstitial irradiation | Iodine-125 | Medicine & Public Health | Oncology | Stereotactic brachytherapy | Inoperable glioblastoma | SURVIVAL | REIRRADIATION | RADIOSURGERY | MALIGNANT BRAIN-TUMORS | INTERSTITIAL BRACHYTHERAPY | TREATMENT OPTION | LOW-GRADE GLIOMAS | CLINICAL NEUROLOGY | RADIATION-THERAPY | SEEDS | ONCOLOGY | RADIOTHERAPY | Neoplasm Recurrence, Local - radiotherapy | Prognosis | Follow-Up Studies | Dacarbazine - therapeutic use | Humans | Middle Aged | Brain Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - mortality | Glioblastoma - radiotherapy | Iodine Radioisotopes - adverse effects | Neoplasm Recurrence, Local - pathology | Young Adult | Iodine Radioisotopes - therapeutic use | Dacarbazine - analogs & derivatives | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Chemotherapy, Adjuvant | Brain Neoplasms - radiotherapy | Brachytherapy - methods | Treatment Outcome | Brain Neoplasms - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Glioblastoma - pathology | Adolescent | Survival Analysis | Aged | Glioblastoma - drug therapy | Glioblastoma - mortality | Brachytherapy - adverse effects | Care and treatment | Chemotherapy | Radioisotope brachytherapy | Analysis | Mortality | Health aspects | Glioblastoma multiforme | Cancer
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 6/2016, Volume 43, Issue 6, pp. 1105 - 1114
Current guidelines for glioma imaging by positron emission tomography (PET) using the amino acid analogue O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) recommend... 
Medicine & Public Health | Orthopedics | TBR max | Oncology | Glioma grading | Nuclear Medicine | Imaging / Radiology | Cardiology | 18 F-FET-PET | TBR | F-FET-PET
Journal Article
Neuro-Oncology, ISSN 1522-8517, 11/2019, Volume 21, Issue Supplement_6, pp. vi143 - vi143
Abstract BACKGROUND Methylation of O-6-methylguanine-DNA-methyltransferase (MGMT) promotor causes gene silencing and has been associated with a favourable... 
Journal Article